Stephen K.L. Chia, Peter A. Fasching, John Crown, Dennis J. Slamon, Sherene Loi, Seock-Ah Im, Michael F. Press, Miguel Martín, Oleg Lipatov, Zbighiew Nowecki, Bozena Kukielka-Budny, Daniil Stroyakovskiy, Isabel Blancas, Kevin Vervier, Zheng Li, Juan Pablo Zarate Gonzalez, Tetiana Taran, Fei Su, Aleix Prat, Aditya Bardia. "Prognostic and predictive impact of baseline gene expression (exp) in the NATALEE trial of adjuvant (adj) ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in HR+/HER2− early breast cancer (EBC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.501